Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir

OBJECTIVES: Co-treatment of HIV and TB in young children is complicated by limited treatment options and complex drug–drug interactions. Rifabutin is an alternative to rifampicin for adults receiving a ritonavir-boosted PI. We aimed to evaluate the short-term safety and pharmacokinetics of rifabutin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Antimicrob Chemother
Glavni autori: Moultrie, Harry, McIlleron, Helen, Sawry, Shobna, Kellermann, Tracy, Wiesner, Lubbe, Kindra, Gurpreet, Gous, Hermien, Van Rie, Annelies
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2015
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4291235/
https://ncbi.nlm.nih.gov/pubmed/25281400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dku382
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items